Synopsis:- The defence PSU remains in focus after broker upgrades, with target prices raised to Rs 565, implying 28% upside. Strong Q3 performance, 30% operating margins, 71% achievement of FY26 order inflow targets, and a solid Rs 73,015 crore order book continue...
Synopsis: Raymond Lifestyle shares gained attention after strong Q3 results and MOSL’s 54 percent upside call, driven by domestic-led recovery, margin expansion, and steady segmental growth. The shares of this company, which is involved in branded apparel, suiting,...
Synopsis: Metro Brands shares jump 5% after Goldman Sachs raises target to Rs 1,340, seeing 30% upside, citing strong 3QFY26 sales, EBIT growth, and sustainable profitability. The share of this company, which offers a diverse collection including casual shoes,...
Synopsis: Tata Motors CV shares are in focus as the UBS Sees 24% Upside potential as it expects India’s commercial vehicles (CV) industry to outperform the passenger car and two-wheeler segments and believes Tata Motors’ CV business is well positioned to capitalise on...
Synopsis:- Axis Direct maintained a ‘Buy’ call with a ₹2,200 target, implying ~43% upside. Volume recovery is expected as 125,000 tonnes of new capacity come online by Q4FY26. Plastic volumes jumped 55% QoQ, margins improved to 12%, and management targets 25% volume...
Synopsis: Jefferies maintains a Buy on Mankind Pharma Limited, citing achievable growth expectations, easing pressures in acute therapies, stronger execution, attractive valuation, and active founder involvement supporting a potential recovery and upside. This...
Synopsis: Jefferies maintains a Buy on Eternal Limited, citing leadership continuity, strong execution at Blinkit, and long-term quick-commerce growth, despite near-term volatility, competition, and investor concerns after Q3 results. This Large-cap Stock, engaged in...
Synopsis: Motilal Oswal has recommended stocks including JSW Steel, JSW Energy, Home First Finance, Atul, CAMS, and Coforge, citing strong fundamentals and potential upside of up to 50% for long-term investors. Motilal Oswal has identified a select list of stocks with...
Synopsis: Citi maintains a high-conviction Buy on the stock with a Rs. 9,600 target, citing 41 percent upside, attractive valuations, strong healthcare demand, and an expected 17 percent EBITDA CAGR through FY28. The company has established itself as Asia’s leading...